Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment

Background: Melphalan was poorly available in mainland China. The aim of this study is to explore the dose-adjusted busulfan/cyclophosphamide (BU/CY) as an alternative regimen in auto stem cell transplantation (ASCT) for multiple myeloma (MM). Methods: A total of 105 newly diagnosed MM patients unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shiyuan, Zhai, Yingying, Yan, Lingzhi, Shi, Xiaolan, Shang, Jingjing, Wu, Depei, Fu, Chengcheng, Jin, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573400/
https://www.ncbi.nlm.nih.gov/pubmed/37834886
http://dx.doi.org/10.3390/jcm12196239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573400/
https://www.ncbi.nlm.nih.gov/pubmed/37834886
http://dx.doi.org/10.3390/jcm12196239

Ejemplares similares